Could InflaRx N.V. (IFRX) Lose Strenght? The Stock Increases A Lot Today

April 21, 2018 - By Linda Rogers

The stock of InflaRx N.V. (NASDAQ:IFRX) is a huge mover today! The stock increased 4.39% or $1.63 during the last trading session, reaching $38.77. About 50,021 shares traded. InflaRx N.V. (NASDAQ:IFRX) has 0.00% since April 21, 2017 and is . It has underperformed by 11.55% the S&P500.
The move comes after 9 months positive chart setup for the $907.64M company. It was reported on Apr, 21 by Barchart.com. We have $40.71 PT which if reached, will make NASDAQ:IFRX worth $45.38M more.

InflaRx GmbH, a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States. The company has market cap of $907.64 million. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The firm is involved developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic/autoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases.

InflaRx N.V. (NASDAQ:IFRX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: